Depression and Acute Coronary Syndrome: Understanding the Connection.

Verified data
16

3 min read

Share

Outline

Depression affects the acute coronary syndrome (ACS) recovery process. Read about the symptoms, risks, and therapies to enhance mental and cardiac health.

Medically reviewed byDaniyal Riaz

Published At December 15, 2022
Reviewed AtApril 22, 2025

Introduction

Clinical depression is a known side effect of acute coronary syndrome (ACS) and is linked to a poor outcome for these patients, even though it is occasionally underdiagnosed. In this study, we investigated the prevalence and contributing factors of depression in patients who had had ACS. The relationship between depression and heart disease is bidirectional.

The Association Between Acute Coronary Syndrome and Depression-

The relationship between Acute Coronary Syndrome (ACS) and depression is complex. Depression, besides being a common outcome of ACS events, is a cardiovascular disease risk factor. Research indicates that there is a double risk of dying from cardiovascular disease and mental health problems. During the first year or two after an acute event, ACS also raises the risk for anxiety or depression. This multifaceted relationship highlights the essential role of opportunistic screening and treatment efforts to optimize patient outcomes in these high-stakes acute care settings.

Depression in ACS Patients- Symptoms and Diagnosis

Symptoms are as follows:

  • Feelings of despair and helplessness.

  • Lack of interest in things you normally loved to do.

  • Alterations in appetite or weight.

  • Changes in sleep, such as oversleeping or difficulty falling or staying asleep, particularly waking up early.

  • Being agitated and "keyed up" or feeling lethargic and physically slowed down.

  • Self-loathing is characterized by severe criticism of one's own perceived flaws and errors or intense feelings of worthlessness.

  • Focusing, decision-making, or memory issues.

Diagnosis of Depression:

Understanding the Score: Exploring the patient’s symptoms in the context of their ACS and what other etiologies might explain these findings will lead a provider to the proper diagnosis. Validated screening instruments such as the Hospital Anxiety and Depression Scale (HADS) or the Patient Health Questionnaire (PHQ-9) may assist in identifying individuals at risk of depression. Through extensive assessment, a mental health professional can determine whether the patient meets the criteria for a depressive condition. Assessing somatic symptoms, like sleep problems and fatigue, which are frequently seen in ACS patients, will clarify whether they are associated with depression or the underlying cardiac illness.

The Effect of Depression on Recovery and Death:

Depression has a serious effect on Acute Coronary Syndrome (ACS) patients in recovery and death:

  • Endothelial Progenitor Cells (EPCs): They are significantly low in circulating EPCs in ACS and major depressive episode (MDE) patients versus healthy individuals. The ability of the body to recover from acute ischemia events could be impaired by this reduction.

  • Physical Health Status: Patients with persistent depression 12 months following ACS are more likely to have worse physical health status.

  • Health Habits: Contrary to expectations, relative to usual care, better depression care did not significantly lead to improvement in the following heart-healthy habits: diet, exercise, or quitting smoking.

  • Mortality Risk: Depression has been linked with a lower chance of survival in ACS patients.

These results highlight the significance of the sustained diagnosis and treatment of depression in ACS patients to improve outcomes. The heart attack and depression association is also under research.

Treatment and Management Strategies-

The treatment and management strategies need to be integrated to control depression in Acute Coronary Syndrome (ACS) patients:

  • An 11-month Integrated Care (IC) approach of:

  • Risk factor control by nurse-directed approaches.

  • Group therapy.

  • Problem-solving therapy is an individual approach.

  • Antidepressant treatment, if deemed necessary, is undergoing a multicenter trial.

  • The mood-care program realized the key improvement.

Depression Management With Cardiovascular Risk Reduction:

  • Depression scores on PHQ-9 reduced by 1.8 points on average, and by 2.7 points, in patients with a history of depression.

  • The effect size in patients with a history of depression is d = 0.65.

  • In ACS patients, routine screening for depression is essential.

  • Heart rehab is indicated as part of overall management.

These are aimed at helping ACS patients with their cardiovascular status and depressive disorder.

Prevention of Depression Following an ACS Episode-

Improvement of patient status following an Acute Coronary Syndrome (ACS) episode includes the prevention of depression. The following evidence-based practices are borrowed from the papers that were submitted:

  • Pharmacological Intervention: Escitalopram substantially decreased the prevalence of depression in patients post-ACS, according to a randomized controlled trial. Contrary to 10 out of 120 control patients, two out of 120 patients were depressed during therapy with escitalopram. The duration of treatment was one year.

  • Early Screening: Since 1.5 percent of patients have early depression (less than 30 days), detecting high-risk patients is crucial. An additional 9.5 percent have depression between 31 days and two years.

  • Risk Factor Management: It involves managing patient characteristics that are linked with an increased risk of depression, such as socioeconomic status, psychological factors, health-related behaviors, somatic comorbidities, and demographics.

  • Integrated Care: Consider the adoption of total programs that include cardiovascular risk reduction and depression treatment.

  • By preventing depression from developing or reducing its incidence in ACS patients, these measures might enhance their prognosis.

Conclusion

Among patients with ACS, depression was rather common. Depression prevalence was associated with female gender, diabetes mellitus, and dialysis treatment, as well as with other factors. Moreover, we found that the degree of depression had no bearing on the in-hospital or 30-day results. Perhaps the small follow-up period caused most of the data to be not statistically significant. Results should thus be repeated in a larger trial with a longer follow-up period to guide future depression screening for ACS patients.

Key Takeaway/ Note from iCliniq

Studies show a strong association between mental health and cardiovascular disease and very poor outcomes in patients with acute coronary syndrome (ACS), suggesting that depression is an independent risk factor and that addressing mental health is crucial for improving cardiac outcomes. Icliniq supports the proper diagnosis of depression in ACS patients.

Listen to related tracks in our music library

Frequently Asked Questions

Acute coronary syndrome reduces blood flow in the heart muscles. The treatment involves medical treatment and lifestyle changes. The surgical procedure includes coronary artery bypass surgery and angioplasty. Maintaining a healthy, balanced diet and regular exercise may prevent the condition.
The medications used to treat ACS are as follows:
- Antiplatelet drugs such as Aspirin and Clopidogrel.
- Anticoagulants such as Heparin.
- Nitroglycerin helps the patient with chest pain.
- Beta-blockers such as Metoprolol and Carvedilol. 
- Angiotensin-converting enzyme inhibitors.
Acute coronary artery syndrome is a serious disease. The condition can block the blood flow to the heart, leading to heart failure or heart attack. The condition causes 400,000 deaths every year. Proper remedies can prevent further harm to the heart. It helps in providing life to the patient.
Coronary artery syndrome is a heart condition in which the arteries are small and lean leading to the obstruction of blood movement to the heart. Heart failure differs from coronary artery syndrome, in which the other parts of the human body do not get enough blood from the heart.
The threats of acute coronary syndrome are as follows:
- The risk of the condition is more after the age 45 years for men and 55 years for women. 
- Hereditary conditions with heart disease.
- High blood sugar levels.
- Being overweight.
- Anxiety and stress.
Several blood tests can help in the diagnosis of the condition.
- Troponin Test: Troponin is a protein that is present in the heart muscle. When the heart muscle is injured, it leads to an increase in troponin levels. 
- Creatinine Kinase-MB Test: The CK-MB enzyme is found in the bloodstream when the heart muscles are damaged. 
- Myoglobin Test: Myoglobin levels are high when there is damage in the heart muscle.
- C-Reactive Protein (CRP) Test: An increase in CRP level may indicate inflammation of the coronary arteries. 
The duration of ACS depends on the quality of the treatment. Unstable angina can last for several hours to minutes with medications. A heart attack can last for several hours to days if untreated. Timely treatment can reduce the risk of further damage to the patient.
Stress can lead to acute coronary syndrome, especially in patients with medical conditions like high blood pressure. Stress can lead to a release of adrenaline and stress hormones like cortisol, which can damage the blood vessels.
Stress can lead to acute coronary syndrome, especially in patients with medical conditions like high blood pressure. Stress can lead to a release of adrenaline and stress hormones like cortisol, which can damage the blood vessels.
The threat of developing ACS increases with age. The possibility of ACS usually increases after the age of 45 years. Other threat factors include smoking, obesity, high cholesterol levels, high blood pressure, diabetes, and a sedentary lifestyle.
The clinical features of the acute coronary syndrome are as follows:
- Chest pain and discomfort.
- Shortness of breath.
- Nausea.
- Vomiting.
- Dizziness.
- Sweating.
Aspirin helps in reducing the risk of cardiac events. Aspirin reduces the blood clot formation in the coronary arteries, leading to a reduction in the blood flow to the heart. Aspirin also inhibits the cyclooxygenase enzyme action, leading to reduced pain, inflammation, and blood clotting.
Beta-blockers can improve blood flow and decrease further damage to the heart muscle. These drugs block the release of catecholamines and lead to a decrease in blood pressure. These drugs also reduce the risk of abnormal heartbeat and recurrent heart attacks. 
Some people are at low risk of developing acute coronary syndrome as follows:
- Individuals with a healthy lifestyle. 
- Younger individuals, particularly those below the age of 40.
- Individuals with no high blood pressure and diabetes.
Acute coronary syndrome does not cause stroke, but it can increase the risk of stroke. The threat factors include high blood pressure and diabetes. These threat factors increase the chances of stroke. In Acute coronary heart disease a blood clot forms in the heart and causes a stroke. 
The best antihypertensive drugs are as follows:
- Beta-blockers.
- Angiotensin-converting enzyme.
- Angiotensin-2 receptor blockers.
- Calcium channel blockers.
Source Article IclonSourcesSource Article Arrow

Tags:

depressionacute coronary syndrome (acs)

Ask a Wellness Expert online

Psychotherapy

*guaranteed answer within 4 hours

Disclaimer: Wellness medicine is not aimed to replace the services of your treating physician or allopathy medicines. Our site's information is to those who are willing to take responsibility for their health, being fully aware that the content published herein would not qualify as a prescription or specific medical advice. If users use the information and stop prescribed medication without their physician's consent, they bear full responsibility for their actions, and iCliniq-Wellness bears no responsibility for the same. Information on Wellness medicine should not be misinterpreted as a cure for any illness, as our body is complex and everyone reacts differently.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy